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ABSTRACT  The  envelope  glycoproteins  of  Rous sarcoma virus (RSV), gp85 and  gp37, are 
anchored in the membrane by a 27-amino acid, hydrophobic domain that lies adjacent toa 
22-amino acid, cytoplasmic domain at the carboxy terminus of gp37. We have altered these 
cytoplasmic and transmembrane domains by introducing  deletion  mutations into the molec- 
ularly cloned sequences of a proviral env gene. The effects of the mutations on the transport 
and subcellular localization of the Rous sarcoma virus glycoproteins were examined in monkey 
(CV-1) cells using an SV40 expression vector. We found, on the one hand, that replacement 
of the nonconserved region of the cytoplasmic domain with a longer, unrelated sequence of 
amino acids (mutant C1) did  not alter the rate of transport to the Golgi apparatus nor the 
appearance of the  glycoprotein  on  the  cell  surface. Larger deletions,  extending  into  the 
conserved region of the cytoplasmic domain (mutant C2), resulted in a slower rate of transport 
to the Golgi apparatus, but did not prevent transport to the cell surface. On the other hand, 
removal of the entire cytoplasmic and transmembrane domains (mutant C3) did block transport 
and therefore  did not result in secretion of the truncated  protein.  Our results demonstrate 
that the C3 polypeptide was not transported to the Golgi apparatus, although  it apparently 
remained in a soluble, nonanchored form in the lumen of the rough endoplasmic reticulum; 
therefore,  it appears that this  mutant  protein  lacks a functional  sorting signal. Surprisingly, 
subcellular localization by internal immunofluorescence  revealed that the C3 protein (unlike 
the wild type) did not accumulate on the nuclear membrane but rather in vesicles distributed 
throughout the cytoplasm. This observation  suggests that the wild-type glycoproteins  (and 
perhaps other  membrane-bound  or  secreted proteins) are  specifically  transported  to  the 
nuclear membrane after their biosynthesis elsewhere in the rough endoplasmic reticulum. 
The mechanism(s) by which cells send membrane-bound and 
secreted proteins to their proper subcellular locations remains 
an enigma of molecular biology. The mechanism presumably 
involves the specific interaction of "sorting signals," located 
within the structure of the newly synthesized proteins, with 
membrane-bound receptors in the rough endoplasmic retic- 
ulum (RER)' and Golgi apparatus of the cell (for review, see 
references 53 and 59). Evidence that protein sorting requires 
such specific interactions has recently been provided by the 
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observation that cells can transport and secrete a variety of 
glycosylated  and unglycosylated  proteins at distinctly different 
rates (10,  18, 36, 38, 61). 
Very little is known about the composition(s) of sorting 
signals, but it is generally thought that they are composed of 
protein. In support of this idea, transport defective mutants 
of secreted proteins have been identified that differ from the 
wild-type forms by one (44,  71) or two (22,  72) amino acid 
substitutions.  Also,  several  conditional  transport  defective 
mutants of membrane-bound viral glycoproteins have been 
identified (for example, 33, 37, 47, 73). Furthermore, studies 
using tunicamycin, an inhibitor of glycosylation, suggest that 
carbohydrate moieties  are  not  recognized directly by  the 
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proper secondary or tertiary structures of (protein-composed) 
sorting signals  (15-17,  23,  52,  61,  63).  An indirect role for 
carbohydrate moieties in the sorting process is perhaps to be 
expected in view of the fact that many secreted proteins are 
not glycosylated at all (see, for example, references 6 l, 67). 
To be sure, the transport of  certain hydrolases to the lysosome 
(and away from the secretory pathway) does appear to require 
the addition of a carbohydrate moiety (mannose-6-phosphate 
[20]), but these additions in turn must require the recognition 
of signals within the polypeptide chains. 
Even less is known about the intramolecular location(s) of 
sorting signals. In the case of the membrane-spanning glyco- 
proteins, three protein domains exist that together or sepa- 
rately may harbor a sorting signal:  (a) the internal or cyto- 
plasmic domain, (b) the hydrophobic or transmembrane do- 
main, and (c) the extracytoplasmic or external domain. Be- 
cause most secreted proteins (which may be co-transported 
with membrane-bound glycoproteins [62]) possess only exter- 
nal domains, it would seem reasonable to expect the trans- 
membrane and cytoplasmic domains to be unimportant to 
the sorting process. This hypothesis has been recently tested 
for the vesicular stomatitis virus (VSV)  G  protein (50) and 
the influenza virus hemagglutinin protein (14, 64). Removal 
of the transmembrane and cytoplasmic domains of both of 
these proteins (by means of in vitro mutagenesis of  the cloned 
genes)  resulted in secretion of the truncated proteins. Fur- 
thermore, removal of portions of the  cytoplasmic domain 
from the Semliki Forest virus E2 glycoprotein (l 2) and from 
the H-2L transplantation antigen of the mouse (45,  74) has 
been shown not to block transport to the cell surface. Subse- 
quently, however, evidence has been obtained that demon- 
strates that the cytoplasmic domain may indeed be important 
for the sorting process. Defined alterations in the cytoplasmic 
domain of the VSV G protein, obtained by in vitro mutagen- 
esis, have shown that deletions within this domain can reduce 
or eliminate transport to the cell surface (51).  Furthermore, 
spontaneous mutants of the vaccinia virus hemmagglutinin 
protein that are blocked in the RER, though not well char- 
acterized by sequencing, have been shown to contain longer 
cytoplasmic domains (58). Thus, the structure and locations 
of sorting signals within membrane-spanning glycoproteins is 
not as obvious as might initially have been thought. 
Unraveling of  the complex nature of sorting signals is likely 
to require the analysis of many well-defined mutant polypep- 
tides. To this end, we have constructed a series of mutations 
in the envelope gene (env) of Rous sarcoma virus (RSV),  an 
avian retrovirus. The RSV env gene codes for two glycopro- 
teins, gp85 and gp37, which are found on the outer surface of 
infectious virions. These proteins are required for the specific 
binding of  the virions to receptors on the surface of  susceptible 
cells and initiate the process of cellular penetration (69). The 
two  glycoproteins are  synthesized as  a  single  glycosylated 
precursor (Pr95e"v), which is subsequently processed to give 
the mature forms (7, 9, 21, 32, 43). Processing appears to take 
place in the Golgi apparatus of infected chicken cells (4, 5), 
and  pactamycin-mapping  experiments  place  gp85  at  the 
amino terminus and gp37 at the carboxy terminus of Pr95  ~"v 
(32,  57). The proteins are linked by disulfide bonds to give 
complexes that contain one molecule ofgp85 and one ofgp37 
(34). Treatment of virions with reducing agents releases only 
gp85, which suggests that gp37 serves to anchor the glycopro- 
teins to the viral membrane (46). The determinants of host- 
range specificity appear to map to gp85 (24, 29, 30). 
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A DNA copy of the entire RSV genome has recently been 
molecularly cloned  (31)  and  sequenced  (56).  Amino  acid 
sequencing of  the amino termini ofgp85 and gp37 has enabled 
the structural and functional regions of the env gene product 
to be deduced (29).  These latter studies have demonstrated 
the presence of a 27-amino acid-long hydrophobic (and pre- 
sumably membrane-spanning) domain and a 22-amino acid- 
long cytoplasmic domain at the carboxy terminus of gp37 
(see Fig. 2). Comparison of these domains with those of other 
exogenous and endogenous strains of RSV has revealed that 
the sequence within the hydrophobic domain is highly con- 
served; furthermore, in the cytoplasmic domain, the sequence 
of the  first  18  amino  acids  (adjacent  to  the  hydrophobic 
domain) is also highly conserved whereas those at the carboxy 
termini diverge greatly (26, 29). 
In  this  paper we report the  importance of the carboxy- 
terminal domains of gp37 for transport of the RSV glycopro- 
teins  to  the  cell  surface.  We  show  that  alteration  of the 
nonconserved region  of the  cytoplasmic domain  does  not 
affect the rate of  transport, but a deletion within the conserved 
region does. Furthermore, deletion of the entire cytoplasmic 
and transmembrane domains does not result in secretion of 
the truncated protein, although it apparently remains soluble 
in the lumen of the rough endoplasmic reticulum. We also 
present evidence that suggests that the nuclear envelope is a 
distinct intermediate compartment between the rough endo- 
plasmic reticulum and the Golgi apparatus.  A  preliminary 
report of some of this work has recently been published (70). 
MATERIALS  AND  METHODS 
DNAs,  Viruses,  and  Cells:  The source of the RSV env gene was 
pATV-8, a recombinant  pBR322 plasmid containing  a complete copy of the 
genome  of the Prague C  strain  (31). The entire  nucleotide  sequence of this 
cloned copy has recently been reported (56). The SV40 late region replacement 
vector used for the expression of wild-type and mutant RSV env genes was 
constructed from wild-type SV40 DNA. SV40 late functions were provided by 
a viable, early deletion mutant, d11055 (48, 49). This SV40 helper genome and 
the SV40 vector genome were molecularly cloned in pBR322 derivatives and 
generously provided by Dr. Mary-Jane Gething and Dr. Joe Sambrook (Cold 
Spring Harbor Laboratory). Control experiments were performed using recom- 
binant SV40 viruses carrying cloned influenza hemagglutinin (HA) genes (also 
obtained from Dr. Oething). The viruses used were SVEHA3 (which expresses 
wild-type HA [l 3]) and SVEHA20A- (which expresses an "anchor-minus" HA 
[14]). 
All  recombinant  bacterial  plasmids  were propagated  in  Escherichia  coil 
strain  DH-I, which  is  recA and hsdR  (40). Transformed  DH-I  cells were 
selected and grown in L medium (per liter, l0 g tryptone, 5 g yeast extract, l0 
g  NaCl)  containing  ampicillin.  The expression  and  characterization  of the 
recombinant  SV40 viruses were studied using CV-1 cells, a continuous line of 
African green monkey kidney cells that are permissive for SV40 replication (l). 
These cells were grown in Dulbecco's modified medium containing  10% fetal 
calf serum. 
Manipulation  of DNAs:  All DNA modification enzymes (restriction 
endonucleases, T4 DNA ligase, Klenow fragment of DNA polymerase I, Bal3 l) 
were purchased from Bethesda Research Laboratories (Gaithersburg, MD). All 
manipulations  and reactions  involving DNA (restriction endonuclease  diges- 
tions, analytical and preparative gel electrophoresis, blunt-end  and sticky-end 
ligations, bacterial  transformation,  plasmid  isolations,  Balm  digestions, end 
labeling, etc.) were performed according to standard  laboratory protocols (40). 
Subcloning and In Vitro Mutagenesis of the env Gene:  The 
1866 base pair (bp) KpnI-Xbal fragment  of pATV-8 contains  the  RSV env 
gene with the sequences coding for the amino terminus of gp85 located near 
the Kpnl site and those for the carboxy terminus of gp37 located near the Xbal 
site (29, 56). This fragment was subcloned into a derivative of pBR322 after 
ligating a BamHI linker to the XbaI end with the use of the Klenow fragment 
of DNA polymerase I and T4 DNA ligase. 
To introduce deletions into the subeloned env gene, plasmid DNA was cut 
at the unique BamHI site and digested for various amounts of time with the 
double-strand-specific exonuclease, Bal31. Reactions giving digestion products 
of the desired size class were identified by digesting aliquots with restriction enzymes and analyzing the products on polyacrylamide gels. The DNA from 
these  Bal31 reactions  was then  ligated in the  presence  of BamHI linkers, 
CCGGATCCGG,  (Collaborative  Research,  Lexington,  MA)  to  restore  the 
BamHI site. After transformation of DH-I cells, clones were screened for the 
presence of  the BamHI site, and then the approximate  size of each deletion was 
determined  by restriction enzyme analysis. The precise endpoints  of the dele- 
tions of interest  were determined  by the  Maxam-Gilbert method of DNA 
sequencing (41 ). 
Construction  of Recombinant SV40 Viruses:  Expressionofthe 
wild-type and mutant env genes was accomplished using an SV40 late region 
replacement  vector. As shown in Fig.  1, KpnI-BamHI fragments  containing 
the env genes were inserted in the place of  the late region of  SV40 DNA between 
the KpnI and BamHl sites. These substitutions  leave a functional  SV40 late 
promoter (6), which allows transcription  of the inserted env genes. The SV40- 
env recombinant DNAs were cloned in the BamHI site of a pBR322 derivative 
and propagated in E. coil cells. Before transfection of CV-I cells, the bacterial 
plasmid sequences (pBR322) were removed by BamHI digestion, and the SV40- 
env sequences were circularized by ligation at low DNA concentration  (4 #g/ 
ml). 
Virions carrying the recombinant SV40-env DNAs were produced in CV-1 
cells by complementation  with a co-transfected  SV40 helper DNA (d11055) 
using a modification of the method of  Gething and Sambrook (13). Briefly, 60- 
mm plates of CV-1 cells (~80%  confluent) were washed once with PBS and 
once with Tris-buffered saline. 500 ~1 of Tris-buffered saline containing 200 ng 
of circularized SV40-env DNA, 75 ng of circularized helper DNA, and 250 tLg 
of DEAE-dextran (42) were added to the monolayers, which were then placed 
at 370C in a CO2 incubator. After 60-90 rain, the cells were gently washed once 
with Tris-buffered saline, once with PBS, and then growth medium containing 
100 #M chloroquine was added for 3-5 h at 37°C (39). The cells were incubated 
in medium without chloroquine for 4-6 d until cytopathic effects were observed. 
High-titer  virus stocks were produced  by freeze-thawing the transfected  cells 
three times and using the lysates to infect fresh monolayers. The resulting virus 
stocks were used at concentrations  that produced  extensive cytopathic effects 
(rounded or vacuolated but still attached cells) in 3-4 d. 
Radiolabeling  of Cells:  Cells were labeled with radioisotopes 50-72 
h after  infection.  Labeling with  o-[2-3H]mannose  (10 Ci/mmol, Amersham 
Corp.,  Arlington  Heights,  IL), o-[6-3H(N)]glucosamine HCl (26.8 Ci/mmol, 
Amersham Corp.),  or L-[5,6-3H]fucosc (84 Ci/mmol, New England Nuclear, 
Boston, MA) was performed in 0.5 ml of serum-free medium for 6 h using 100 
/~Ci of labeled sugar. Cells to be pulse labeled with L-[4,5-3H(N)]leucine (50 Ci/ 
mmol, New England Nuclear) were starved for 1 h in leucine-free, serum-free 
medium and then incubated with 0.25 ml of  the same medium containing 250 
uCi of [3H]ieucine for 15 rain. Chases with unlabeled leucine were performed 
in 2 ml of growth  medium after  removing  the labeling medium.  For those 
experiments  where  quantitation  between  pulse  and  pulse-chase  plates  was 
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FIGURE  1  Generalized structure  of the SV40 late region replace- 
ment vector used for the expression of the mutant RSV env genes 
in CV-1  cells. The region of" env coding for the amino terminus of 
the  glycoprotein  product  is  located  near  the  Kpnl  site.  Three 
mutations (designated C1, C2, and C3) in the sequences coding for 
the carbo×y terminus were constructed  in vitro usin  8  the exonu- 
¢lease, Ba131. The site of the deletions in the env gene is indicated 
by the triangle. 
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critical, great care was taken to treat all the plates identically (the same amount 
of cells, virus inoculum,  radioisotope,  etc., were used), and each experiment 
was repeated two to three times. 
Immunoprecipitation of Viral Polypeptides:  Radiolabeledcells 
were detergent lyscd as described before (29). To examine the culture fluids for 
secreted viral proteins, we centrifuged the medium to remove loose cells and 
then mixed with detergents (19). Viral proteins were immunoprecipitated  using 
an excess of antiviral  antibodies  (anti-gp85/anti-gp37  or anti-HA)  and the 
immune complexes were collected with fixed Staphylococcus  aureus  as previ- 
ously described (13, 29). The anti-gp85 and anti-gp37 antibodies were prepared 
using detergent-treated,  gel-purified RSV glycoproteins and have been shown 
to react with both glycosylated and nonglycosylated forms of the RSV glyco- 
proteins (29). 
SDS Polvacrylamide Gels:  Immunoprecipitated  viral polypeptides 
were  reduced,  denatured,  and  electrophoresed  in  1.5-ram-thick  SDS--Tris- 
glycine slab gels containing  10% acrylamide  as described previously (29). To 
quantitate  the amount of radioactivity in bands of viral protein, we carefully 
cut out the bands of the dried gel and soaked them overnight at 37°C in 0.4 ml 
of 90%  Protosol  (New  England  Nuclear).  4  ml  Omnifluor (New  England 
Nuclear)  toluene was then added, and the radioactivity present was measured 
in a liquid scintillation counter. 
Fluorescent Staining of Cells:  CV-1  cells were grown on coverslips 
in 35-ram plates and stained after 50-65 h of infection. To identify the internal 
locations  of the  viral  proteins,  we  performed  ind/rect  immunofluorescent 
staining on cells fixed with 95% ethanol, 5% glacial acetic acid (vol/vol). Rabbit 
antiviral  antibodies  (anti-gO85 or anti-HA)  were added  for 30 min at room 
temperature,  and after washing the excess antibodies away, fluorescein-conju- 
gated goat anti-rabbit  IgG (Antibodies Inc., Davis, CA) was added for 30 min 
at  room  temperature.  After  thoroughly  washing,  the  coverslips  were  wet 
mounted on slides using 50%  glycerol, 50%  PBS containing  0.1% BSA. To 
stain the Golgi apparatus (68), we first stained the fixed cells immunofluores- 
cently as described above. After washing away the excess floorescein labeled, 
rhodamine-conjugated  wheat germ agglutinin (E. Y. Laboratories, San Marco, 
CA) diluted  1:10 with PBS was added  for 30 min at room temperature.  The 
excess rhodamine label was then washed away, and the coverslips were mounted 
as described above. To detect viral proteins on the surface of infected cells, we 
used live cells, and all steps were carried out at 4°C. The cells were thoroughly 
washed and antiserum  from RSV-PRC  infected  chickens was added  for 30 
min. This antiserum reacts strongly with the antigenic determinants  present on 
native (non-detergent-treated)  RSV glycoproteins. The cells were then washed 
and fluorescein-conjugated rabbit anti-chicken IgG (Antibodies Inc.) was added 
for another 30 rain. After washing, the cells were fixed with 95% ethanol,  5% 
glacial acetic acid for 15-30 rain. The coverslips were then washed and mounted 
as described above. All photographs were made on a Nikon Fluophot fluores- 
cence microscope (Nikon  Inc., Garden City, NY) using a x  40 objective, and 
Kodak  Tri-X  Pan  film (400 ASA, Eastman Kodak  Co., Rochester, NY) was 
used for black and white negatives. 
Fractionation of Infected Cells:  Cells were fractionated into cy- 
tosol and membrane portions by the general method of Dickson and Atterwill 
(8). CV-1 cells were infected and (after 57 h) either pulse labeled or pulse--chase 
labeled (4-h chase) with [3H]leucine and washed twice with ice cold PBS. The 
cells were then scraped off the plates in PBS, pelleted at 2,000 g for 5 rain, and 
resuspended in hypotonic  buffer (1 mM MgCIs, 2 mM NaHCO3). After incu- 
bating for 10 rain on ice to allow swelling, the cells were ruptured by Dounce 
homogenization.  Nuclei and unbroken cells were pelleted by centrifugation at 
2,000 g for 10 rain. The resulting supernatant was centrifuged at 50,000 rpm 
in Beckman  SWS0.1 rotor (250,000 g, average, Beckman  Instruments, Inc., 
Fullerton,  CA)  for  15  rain at  4°C. The cytosol  fraction  (supernatant)  and 
membrane fraction  (pellet) were adjusted  to equal  volumes using detergent- 
containing  buffers, and the viral proteins were immunoprecipitated  and elec- 
trophoresed as described above. 
R  ES U LTS 
Construction and Expression of Deletion 
Mutations Altering the Carboxy Terminus 
of Pr95  env 
The env gene of the Prague C strain of RgV is contained in 
a  KpnI-XbaI fragment  of the  proviral  DNA  (56).  The  se- 
quences coding for the amino terminus of Pr95  e"v are located 
near the KpnI site, and those coding for the carboxy terminus 
are located near the XbaI site. Deletions were introduced into 
the env gene by digesting from the XbaI end with the double 
ET ^L.  Transport-defective Glycoproteins  of Rous Sarcoma Virus  2013 strand-specific exonuclease, Bal31  (see Materials and Meth- 
ods).  BamHI linkers were ligated to the digested ends, and 
the  mutant  env  genes were cloned between the  KpnI and 
BamHI sites into the late region of SV40 DNA (Fig.  1). This 
arrangement puts the env genes under the control of  the SV40 
late promoter. Codons for the termination of  protein synthesis 
were provided by the SV40 sequences flanking the BamHI 
site. 
Before characterizing the phenotypes of the env mutations, 
recombinant SV40 virus stocks were prepared. For this pur- 
pose, each recombinant SV40-env  DNA (vector DNA) was 
co-transfected into monkey kidney (CV-I) cells along with 
the DNA of an SV40 early region deletion mutant (helper 
DNA). Complementation of the early SV40 functions (of the 
vector DNAs)  with the  late SV40  functions (of the helper 
DNA)  enabled  the  production  of infectious,  recombinant 
SV40  virions (13).  These high-titer virus stocks were then 
used to  infect fresh monolayers of CV-I  cells  in  order to 
characterize the wild-type and mutant RSV giycoproteins. 
The endpoints of the deletions were determined by DNA 
sequencing, and the results were used to predict the amino 
acid sequences of the mutant polypeptides. These predictions 
are shown in Fig. 2. Mutant C1 polypeptides are predicted to 
lack the  five amino  acids at  the  carboxy terminus  of the 
cytoplasmic domain; these amino acids are replaced by 20 
"foreign" amino acids (coded by the BamHI linker and adja- 
cent SV40 sequences). In effect, the Cl  polypeptide has lost 
one nonconserved sequence and gained another (longer) one 
at the end of gp37.  Mutant C2 polypeptides are predicted to 
lack  15  amino acids of the cytoplasmic domain which are 
replaced by four foreign amino acids. Thus, a large portion of 
the  conserved  region  of the  gp37  cytoplasmic domain  is 
missing from the C2  polypeptide. Mutant C3  polypeptides 
are predicted to lack the entire cytoplasmic domain, the entire 
hydrophobic domain, and a portion (46 amino acids) of the 
external domain of gp37; these are replaced by the same 20 
foreign amino acids that are appended to the C1 polypeptides. 
In structure, the C3 polypeptide resembles the anchor-minus 
polypeptides of the VSV G  protein (50) and the influenza 
virus HA  protein (14,  64) that  have been  reported to  be 
secreted. It should be noted that none of  the mutant polypep- 
tides described in this report contain the SV40-coded, "trans- 
port-poison"  sequence  that  has  been  found  to  affect the 
transport of certain mutant VSV G  proteins (51).  Further- 
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................................... 
ILE  ASP  GLU  PHE  GLY  GLN  THR  THR  THR  ARG  MET  GLN  *'* 
FIGURE  2  Predicted  primary structures of the mutant polypeptides.  (A) Schematic diagram  of the precursor product of env 
(Pr95  e"v) showing  the relative  endpoint and number  of amino  acids deleted from the carboxy  terminus for each of the three 
mutants (CI, C2, and C3). The box represents  the 27 amino acids of the membrane  anchor region  of gp37. (B) Amino acid 
sequences near  the carboxy  terminus of each of the mutant polypeptides  as predicted  by DNA sequencing.  The underlined 
amino acids correspond  to those of the transmembrane, hydrophobic  anchor region of gp37. Protein synthesis termination 
coclons (***) were provided  by the adjacent  sequences  of the SV40  vector DNA. This foreign  amino  acids  coded by the BamHl 
linker  and SV40  DNA sequences  are indicated  by uppercase  letters. 
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previously identified (29), 
Preliminary Characterization of the 
Mutant Polypeptides 
Experimental evidence in support of the predicted amino 
acid sequences of the mutant polypeptides was obtained from 
the  electrophoresis of the  proteins  in  SDS  polyacrylamide 
gels.  CV-I  cells infected  for 62  h  with  recombinant SV40 
viruses were pulse labeled with [3H]leucine for  15  rain and 
either detergent lysed immediately or chased with unlabeled 
leucine for 2, 4, or 8 h and then lysed. The RSV glycoproteins 
were collected by immunoprecipitation using a  mixture of 
anti-gp85  and  anti-gp37  antibodies.  These  antibodies were 
prepared using detergent-treated, gel-purified gp85 and gp37. 
Anti-gp85  and  anti-gp37  recognize  both  glycosylated  and 
unglycosylated forms of  the RSV glycoproteins in the presence 
of detergents (29).  The collected proteins were separated in 
SDS polyacrylamide gels, and the fluorogram from one such 
gel is shown in Fig. 3. 
After the  pulse,  the  labeled polypeptides of each mutant 
were contained in a single band. Whereas those of Cl and C2 
were similar in size to the wild-type product, the mutant C3 
polypeptide was noticeably smaller in molecular weight. The 
size difference is consistent with the predicted, net deletion of 
75 amino acids. During the chase, the electrophoretic mobility 
of the wild-type, mutant Cl, and mutant C2 precursors in- 
creased  slightly.  These  increases  are  probably  due  to  the 
removal of glucose and mannose residues from the oligosac- 
charide  side  chains  (4),  which  occurs in  the  RER  and  cis 
compartment of the  Golgi apparatus (25).  In  contrast,  the 
mutant  C3  polypeptides  maintained  the  same  mobility 
throughout the chase. This result suggested that the oligosac- 
charide  side  chains  of this  mutant  glycoprotein  are  not 
trimmed back,  perhaps due  to a  block in  transport to  the 
Golgi apparatus. (The existence of such a block will be dem- 
onstrated in subsequent sections of this paper.) 
During  the  chase,  gp85  and  gp37-related  proteins  were 
produced  in  cells expressing the  wild-type,  mutant  C l,  or 
mutant C2 precursors. The amounts of these cleavage prod- 
ucts reached a plateau level in all three cases.  The failure of 
gp85 and gp37-related proteins to accumulate to high levels 
is presumably due to their degradation because none could 
be detected  in  the  culture  medium  even under  conditions 
where anti-gp85  and  anti-gp37  would be expected to  react 
with such products (in the presence of detergents).  Because 
these  proteins  appear  on  the  cell  surface  (see  below),  we 
assume that degradation occurs after transport to that loca- 
tion. Mutant C l has been found to consistently produce lower 
steady-state levels  of gp85  and  gp37-related  proteins  even 
though  the  C1  precursor appears to be processed at a  rate 
identical to wild-type (see below). Differences in the steady- 
state levels of the cleavage products probably reflect differ- 
ences in their degradation rates; however, we have not tested 
this hypothesis. In contrast, mutant C3 polypeptides were not 
cleaved and were degraded very slowly during the chase. This 
latter result is consistent with the hypothesis that there is a 
block in  transport  of this  protein  to  the  site  of precursor 
cleavage, as described above (and demonstrated below). 
As expected from the method of mutant construction, the 
electrophoretic mobilities of gp85 produced in cells expressing 
the wild-type, mutant Cl, or mutant C2 polypeptides did not 
differ. Differences were only observed in the mobilities of the 
gp37-related proteins. The gp37 of mutant C2 was found to 
be smaller than that of the wild type, as predicted by the DNA 
analysis.  The  gp37  of mutant  C1,  however,  appeared as  a 
doublet band in  the gel.  The reason for this doublet is  not 
certain,  but  it  may be  that  the  pattern  of oligosaccharide 
addition  and  modification  is  altered  by the  C l  mutation. 
FIGURE  3  Characterization of the mutant polypeptides and their rate of transport from the  RER. Plates of CV-I  cells  were 
infected with recombinant SV40 viruses carrying wild-type or mutant (CI -C3) env genes. After 62 h of infection, the cells were 
pulse labeled with [3H]leucine for 15 min and either lysed or chased with unlabeled leucine for 2, 4, or 8 h and then lysed. RSV 
glycoproteins were immunoprecipitated  with a mixture of anti-gp85 and anti-gp37 antibodies, electrophoresed in SDS polyacryl- 
amide gels, and fluorographed. An example of one such fluorogram is shown. (VPI  is an SV40 coat protein that is nonspecifically 
isolated during immunoprecipitation.) To determine the relative amount of precursor remaining at each time point, the Pr95  e'v 
bands were cut out of the gels and solubilized, and the radioactivity present was measured in a liquid scintillation counter. Each 
experiment  was repeated three times, and the averages for each time point are shown in the graph. The circled triangle represents 
the average fraction of precursor remaining when cells infected with mutant C2  were pulse labeled at 50, 62,  or 71  h after 
infection and chased for 6 h. Details of these experiments can be found in Materials and Methods. 
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ently been found to migrate more slowly than the bulk of the 
wild-type gp37, and thus the mutant C1  polypeptide appears 
to be larger than wild type, as predicted. 
Effects of the Mutations  on the Rate of Precursor 
Transport from the RER 
Processing of Pr95 e'v to produce gp85 and gp37 most likely 
occurs in  the Golgi apparatus of CV-1  cells before the  for- 
mation of complex oligosaccharides (manuscript in prepara- 
tion). Evidence consistent with this was obtained by labeling 
cells expressing  env  with  [3H]palmitic acid  (a  presumptive 
marker for the cis compartment of the Golgi apparatus [54, 
55]) or [3H]fucose (a marker for the trans Golgi compartment 
[25]).  Briefly,  Pr95 env  was  found  to  be  labeled  with  [3H]- 
palmitic acid but not with [3H]fucose indicating that precursor 
cleavage occurs at an intermediate step during transport (data 
not shown). These results suggested that measurements of the 
rate of precursor disappearance--concomitant with the  ap- 
pearance of cleavage products--could be used to determine 
the rates of transport to the Golgi apparatus (see Discussion). 
To  measure  their  rates  of transport,  the  wild-type  and 
mutant  precursor  polypeptides  were  pulse  or  pulse-chase 
labeled with [3H]leucine (as described above), immunoprecip- 
itated,  and  electrophoresed in  an  SDS  polyacrylamide gel. 
After determining their positions in the dried gel by fluorog- 
raphy the bands containing the precursors were excised from 
the gel, solubilized, and the amount of radioactivity in each 
band was measured. This experiment was repeated three times 
for  the  wild  type  and  each  mutant.  The  fraction  of the 
FIGURE  4  Surface immunofluorescence of cells infected with  re- 
combinant SV40 viruses. Live CV-1  cells expressing wild-type (panel 
a),  mutant Cl  (panel b), mutant C2  (panel c), or mutant C3  (panel 
d) env gene products were exposed to chicken anti-RSV antibodies 
(specific  for  native  RSV  glycoproteins)  and  then  to  fluorescein- 
conjugated  rabbit anti-chicken  IgG as described  in  Materials and 
Methods. As controls, cells infected with recombinant SV40 viruses 
expressing a  membrane-bound, wild-type HA  polypeptide (panel 
e) or a secreted, anchor-minus HA polypeptide (panel f) were also 
examined using the appropriate antisera. The mutant C3  polypep- 
tides did not appear on the surface of infected cells. 
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precursors remaining at each of the time points (relative to 
the pulse) was calculated for each experiment, and the average 
values from all three experiments are plotted in Fig. 3. From 
this graph, it is clear that mutant C 1 polypeptides disappear 
(that is, are cleaved) at about the same rate as the wild-type 
polypeptides with a half-life of 2.5-3.0 h. On the other hand, 
mutant  C2  and  mutant  C3  polypeptides  disappear  more 
slowly with half-lives of 4.5 and 8 h, respectively. 
It could be argued that the populations of cells expressing 
the  mutant C2  or C3  polypeptides die  at a  faster rate and 
therefore exhibit net rates of transport that are slower than 
those of the cells expressing the wild-type or CI polypeptides. 
That is, the results in Fig.  3 might be hypothesized to reflect 
differences in the tilers of SV40-env recombinant viruses used 
to infect the CV-I cells.  However, this hypothesis does not 
seem likely inasmuch as the progression of CPE (cytopathic 
effects) observed with  each virus stock appeared to be the 
same. Nevertheless, we further explored the  possibility that 
the transport rate might decrease as the infection progressed. 
To this end, identical plates of cells expressing the mutant C2 
polypeptides were either pulse labeled or pulse labeled and 
chased for 6  h at the following times after infection: 50,  62, 
or 71 h. We found that time (after infection) had no effect on 
the fraction of precursor remaining after the chase, although 
the total amount of labeled protein increased. The values we 
obtained (0.45,  0.51,  and  0.50,  respectively) were averaged 
and  plotted  on  the  graph  in  Fig.  3  (circled  triangle).  In 
summary, the differences in precursor transport illustrated in 
Fig.  3 are indeed due to the mutations of the env gene and 
not due to artifacts of the SV40 expression system. 
Surface Immunofluorescence  of Cells Expressing 
the Wild-type and Mutant Polypeptides 
To determine if any of the mutations block the transport 
of the RSV glycoproteins to the surface of infected cells, the 
live infected cells  were reacted with chicken anti-RSV anti- 
bodies (which  recognize the  antigenic  determinants  of the 
non-detergent-treated  glycoproteins  and  were  found  to  be 
most effective in surface immunofluorescence assays), stained 
with  fluorescein-conjugated  rabbit  anti-chicken  IgG,  fixed, 
and  examined by fluorescence microscopy. Photographs of 
typical cells are shown in Fig. 4. We found that the wild-type 
(a), mutant C 1 (b), and mutant C2 (c) polypeptides all appear 
on the surface of infected cells.  As a control, we also stained 
(using anti-HA antibodies) cells expressing the wild-type HA 
of influenza virus (Fig. 4, e), which is known to be expressed 
on the surface of CV-1  cells infected with SV40-HA recom- 
binant  viruses (13).  No  attempts were  made to  quantitate 
differences in the intensities of surface fluorescence exhibited 
on the cells, but we have observed consistently lower levels of 
surface fluorescence with mutant C2-infected cells--whether 
this reflects a  slower rate of transport to the  surface is  not 
certain. 
No fluorescence was detected on the surface of any of the 
cells expressing the C3 polypeptides (panel d).  This result is 
consistent with the evidence that transport of the C3 polypep- 
tide to the cell surface is blocked.  On  the  other hand,  this 
result would  also  be  predicted  if the  small  amount  of C3 
polypeptide observed to disappear during a chase (see Fig.  3) 
was secreted, albeit slowly,  from the cell,  because, as shown 
in panel f, anchor-minus HA polypeptides cannot be detected 
by surface fluorescence even though  they are efficiently se- 
creted from CV- 1 cells (14). Examination of Culture Medium for 
Secreted Glycoproteins 
To determine if the mutant C3  polypeptides are secreted, 
we examined the culture medium from infected CV-1  cells 
for the  presence of immunoprecipitable glycoproteins. For 
this  experiment, monolayers were infected with  a  dilution 
(1:50) of recombinant SV40 virus that gives optimum expres- 
sion of  the mutant C3 env gene. To provide an internal control 
for protein  secretion, the  monolayers were  simultaneously 
infected with dilutions of another recombinant SV40 virus 
(SVEHA20A-), which expresses a secreted form of the influ- 
enza  HA  protein  (designated  HAa-  [14]).  At  the  highest 
concentration, close to  100% of the cells were infected with 
SVEHA20A-. After 60 h  of infection, the cells were pulse- 
labeled with [3H]leucine,  chased for 5 h with unlabeled leu- 
cine,  and  divided into  culture medium  and  cellular lysate 
fractions. The electrophoretic results obtained after immu- 
noprecipitation in the presence of detergents with antibodies 
specific  for either RSV  glycoproteins (anti-gp85  and  anti- 
gp37) or HA protein are shown in Fig. 5. Virtually all of the 
labeled C3 protein was found to be cell associated after the 
chase whether co-infecting (HAa--producing) virus was pres- 
ent  (plates  B-D)  or  not  (plate A).  In  the  same  cultures, 
however, virtually all the labeled HAa- protein was found in 
the culture medium after the chase whether co-infecting (C3- 
producing) virus was present (plates B-D) or not (plate E). 
Trace amounts of RSV-specific protein (barely visible  in 
the autoradiogram) were present in the medium. The amount 
present  is  clearly  less  than  would  be  predicted  from  the 
kinetics of precursor disappearance illustrated in Fig. 3 (30% 
of the total after a 5-h chase) and did not appear to increase 
during extended periods of chasing (data not shown) or with 
increasing amounts of  coinfecting virus. It is not clear whether 
this  represents  protein  spilt  from  disrupted  cells  or  trace 
amounts of truly secreted protein. It seems unlikely that the 
C3 protein is secreted and then adsorbed to the surface of the 
CV-1 cells because the results of the surface immunofluores- 
cence experiments (Fig.  4) and  the  subcellular localization 
experiments (described below) argue against this. 
Subcellular Localization of the Mutant 
C3 Polypeptides 
Inasmuch as the C3 polypeptide was severely slowed (if not 
blocked) in transport to the cell surface, we sought to deter- 
mine the site of the barrier along the transport pathway. The 
results of the preliminary characterizations suggested that the 
block  occurs before transport to  the  Golgi  apparatus  (see 
above; Fig.  3). To test this hypothesis, we (a) labeled wild- 
type and  mutant C3  polypeptides with radiolabeled sugars 
that  are  known  to  be  added  at  specific  points  along  the 
transport pathway and (b) stained fixed, infected cells with a 
rhodamine-labeled,  Golgi-specific lecithin  and  fluorescein- 
labeled anti-gp85 antibody to localize the env-specific  glyco- 
proteins relative to the Golgi apparatus. 
For the  radiolabeling experiment, CV-I  cells  expressing 
either the wild-type or mutant C3 polypeptides were labeled 
for 6 h with [3H]mannose (Man), [3H]glucosamine (GL), or 
[3H]fucose  (Fuc). The results obtained after electrophoresis 
and  fluorography of the immunoprecipitated glycoproteins 
are shown in Fig. 6. In the case of fucose labeling,  we found 
that the wild-type gp85 and gp37 (but not Pr95  env) were well 
labeled. As  mentioned above, this result demonstrates that 
Pr95  e~v is cleaved before the addition of fucose in the trans 
Golgi compartment. In  contrast, the C3  polypeptides were 
not labeled with fucose, nor were any labeled cleavage prod- 
ucts detected. This result indicates that the transport block 
FIGURE  5  Examination of culture fluids for the presence of secreted mutant C3  polypeptides. Four plates of CV-1  cells were 
infected with 0.25  ml of recombinant SV40  viruses carrying mutation C3 (1:50 dilution}. As an internal control, these cells were 
co-infected with dilutions of SVEHA20A-  (a recombinant SV40  virus that expresses a secreted, anchor-minus HA  polypeptide): 
no co-infecting virus (plate A), 0.25  ml of 1:100 diluted SVEHA20A-  (plate B), 0.25  ml of 1:10 diluted SVEHA20A-  (plate C), or 
0.5  ml of  1:10 diluted SVEHA20A-  (plate D). A  fifth  plate was infected only with 0.25  ml of 1:10 diluted SVEHA20A-  (plate E). 
After 60 h of infection, the cells were pulse labeled with [3H]leucine and then chased for 5 h with unlabeled leucine. The cultures 
were fractionated into cellular (c) and culture medium (m) portions having the same volume. Equal volumes of each fraction were 
immunoprecipitated with  either a  mixture of anti-gp85 and anti-gp37 antibodies or anti-HA antibodies. The  results from SDS 
PAGE and fluorography are presented. Mutant C3 polypeptides were not found in the culture medium. 
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with [3H]sugars. Cells infected with 60 h were labeled for 6 h with 
100/~Ci of [3H]mannose, [3H]glucosamine, or [3H]fucose. The cells 
were then lysed; the env-coded glycoproteins were immunoprecip- 
itated  with a mixture of anti-gp85  and  anti-gp37 antibodies, and 
the collected proteins were separated  in  an SDS  polyacrylamide 
gel. Fucose  was not incorporated into mutant C3 polypeptides. 
occurs before the  site of fucose addition  and  suggests  that 
transport may be blocked in the RER. In the case of mannose 
and glucosamine labeling, we found that the wild-type Pr95 en~ 
was well labeled, as was expected in that both of these sugars 
are incorporated into the dolichol-linked oligosaccharides that 
are co-translationally transferred to the polypeptide backbone 
in the RER (25).  In Fig. 6, it can also be seen that wild-type 
gp85 and gp37 were better labeled with [aH]glucosamine than 
with [3H]mannose, although the amounts of labeled Pr95 "~ 
were  similar.  This  observation is  consistent  with  the  well- 
characterized  events  of  oligosaccharide  processing  during 
which  the  number  of mannose  residues  decrease  and  the 
number  of glucosamine  residues  (in  N-acetylglucosamine) 
increase during transport from the RER to the Golgi appara- 
tus (25). In contrast, the amount of radioactivity incorporated 
into the C3 polypeptide was about the same for both [3H]- 
mannose and [3H]glucosamine, indicating that the oligosac- 
charide side chains of the C3 polypeptide are not processed 
to the same extent as those of the wild type and supporting 
the concept that transport from the RER to the Golgi appa- 
ratus  does not  occur.  This  hypothesis is  supported  by the 
finding that none of the C3 protein is resistant to endoglyco- 
sidase H (Endo H) digestion (data not shown). 
To determine the subcellular location of the wild-type and 
mutant C3 polypeptides by fluorescence microscopy, we acid- 
alcohol  fixed  infected  cells  65  h  after infection.  The  env- 
specific proteins were located by immunofluorescence after 
staining with fluorescein-conjugated antibodies. To determine 
the position of the Golgi apparatus, we also stained the same 
cells with rhodamine-conjugated wheat germ agglutinin (68). 
Photographs of the typical patterns of fluorescence observed 
are shown  in  Fig.  7.  For cells expressing the  wild-type env 
gene, the fluorescein label (Fig.  7, al  and bl) was found to 
define three distinct regions: (a) a  bright area to one side of 
each nucleus, (b) a bright, distinct ring around each nucleus 
(indicated with short arrows), and (c) a  diffuse network ex- 
tending throughout the cytoplasm. It is widely accepted that 
these regions correspond to (a) the Golgi apparatus, (b) the 
nuclear  membrane, and (c) the  endoplasmic reticulum  (re- 
spectively). Proof that the wild-type protein is indeed trans- 
ported to the Golgi apparatus was obtained with the rhoda- 
mine label (Fig.  7, a2 and b2) whose fluorescence was found 
to coincide with the bright regions of fluorescein fluorescence 
to one side of each nucleus.  In contrast, for cells expressing 
the C3 polypeptide, the fluorescein label (Fig.  7, cl  and dl) 
was only found to reside in  one of the three compartments 
defined  by the  wild-type protein,  namely the  endoplasmic 
reticulum.  No  tings were ever observed around  any of the 
nuclei,  and dark,  nonfluorescent areas (indicated with long 
arrows) were always observed over the Golgi complexes. These 
observations held  true  for  all  times  after  infection  during 
which expression of the env genes could be detected (45-72 
h). Proof that the dark areas indicate the position of the Golgi 
apparatus was obtained with the rhodamine label (Fig.  7, c2 
and d2) whose fluorescence was found to coincide with these 
dark areas rather than the position of the  fluorescein label. 
These results show that transport of the C3 protein is blocked 
-at a very early step in the RER. Furthermore, it suggests that 
transport of the wild-type env product to the nuclear mem- 
brane occurs in a specific manner after synthesis elsewhere in 
the RER. 
Fractionation of Cells Expressing Mutant 
C3 Polypeptides 
The failure of a mutant protein to be transported could be 
due to either (a) the loss of a sorting signal or (b) the loss of 
FIGURE 7  Double fluorescent staining to determine the intracellular  locations  of the wild-type or mutant C3 polypeptides  relative 
to the Golgi apparatus. Cells infected for 65 h with recombinant SV40 viruses carrying either wild-type (panels a and b) or mutant 
C3 (panels c and d) env genes were fixed and treated sequentially with rabbit anti-gp85  antiserum, fluorescein-conjugated  goat 
anti-rabbit IgG, and then rhodamine-conjugated wheat germ agglutinin (as described  in Materials and Methods).  The panels on 
the left (al-dl) show the cellular locations of the env-coded polypeptides (as indicated by the fluorescein-labeled probe), and 
the panels on the right (a2-d2) show the positions of the Golgi apparatus (as indicated by the rhodamine-labeled probe) in the 
same cells. The short arrows in panels al and bl point to the bright rings of fluorescence around the nuclei, and the long arrows 
in panels cl and dl  point to the dark areas of nonfluorescence as described in the text. The mutant C3 polypeptides (unlike 
those of the wild type) were not found in the Golgi and did not form a ring around the nucleus. 
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determine which of these situations exists for the C3 protein, 
infected CV-1  cells  were pulse  labeled with  [3H]leucine  or 
pulse labeled and chased for 4 h. The cells were disrupted by 
Dounce homogenization in detergent-free, hypotonic buffer 
and the unbroken cells and nuclei were removed by low-speed 
centrifugation. The cleared homogenates were then centri- 
fuged at  250,000 g  for  15  min to separate the membranes 
(pellet) from the cytosol (supernatant). As controls, the same 
fractionation was performed using cells expressing the wild- 
type env glycoproteins (wt), the influenza virus hemagglutinin 
(HA), or the anchor-minus hemagglutinin (HAa-). The results 
obtained after immunoprecipitation (in the presence of  deter- 
gents), electrophoresis, and fluorography are presented in Fig. 
8. 
The pulse-labeled wild-type env product (Pr95  env) and HA 
protein were both found to pellet with the membranes during 
the high-speed centrifugation. This result was expected in that 
both of these proteins possess membrane-spanning domains. 
Likewise, after the chase, the wild-type env products (Pr95  end, 
gp85, and gp37) and the HA protein were still (as expected) 
associated with only the membrane fractions. In contrast, the 
pulse-labeled  HAa-  protein  was  found  in  about  equal 
amounts in both the membrane and cytosol fractions. This 
result indicates that the HAa- proteins remained soluble and 
were capable of leaking out of the lumen of the RER in the 
hypotonic conditions employed in the experiment. Because 
the HAa- proteins are rapidly transported and secreted from 
CV-1  cells,  no cell-associated HAa- remained after the 4-h 
chase. 
The behavior of the C3 protein was similar to that of the 
HAa- protein, except that the C3 protein (as expected) was 
not secreted during the chase. Approximately  half  of  the pulse- 
labeled and pulse-chase-labeled C3 protein was found to leak 
from  the  lumen  of the  RER  into  the  cytosol during  the 
fractionation. These results,  though not conclusive (see Dis- 
cussion),  are  consistent  with  the  supposition  that  the  C3 
polypeptides remain soluble in vivo, and that the formation 
of aggregates  of insoluble protein is not the reason why this 
mutant glycoprotein is not transported from the RER. 
DISCUSSION 
We  have  constructed  and  characterized  carboxy terminal 
mutants of  the RSV glycoprotein and have demonstrated that 
the amino acids in this region are important for transport to 
the cell surface. The novel features of these mutant glycopro- 
teins and the limitations of our interpretations are discussed 
below. 
Mutant C3 
The mutant C3 glycoprotein lacks the cytoplasmic domain, 
the transmembrane domain,  and a  portion of the external 
domain  of the  RSV  precursor, and  thereby resembles the 
anchor-minus glycoproteins of VSV (50) and influenza virus 
(14, 64). To be sure, the size of the C3 deletion is proportion- 
ately larger than some of these anchor-minus forms (14, 50), 
but it is also much smaller than others (64). We cannot rule 
out a  very slow  rate of transport, but unlike all  previously 
reported anchor-minus proteins, the C3 glycoprotein does not 
appear to be secreted, and accumulates in the RER. 
Perhaps the most interesting feature of mutant C3 polypep- 
FIGURE 8  Fractionation  of cells expressing wild-type and mutant C3 polypeptides. Cells infected for 57 h were either pulse- 
labeled with [3H]leucine and osmotically lysed or pulse-labeled,  chased for 4 h, and then lysed. Cell lysis was accomplished in 
the absence of detergents  by Dounce homogenization in hypotonic buffer.  Nuclei and unbroken cells were removed by low- 
speed centrifugation, and the resulting cleared lysate was fractionated by ultracentrifugation at 50,000 rpm in an SW50.1 rotor 
(250,000 g, average) for 15 min. The viral polypeptides present in the supernatants (soluble or cytosol fraction [c]) and the pellets 
(membrane fractions [m]) were immunoprecipitated and electrophoresed in SDS polyacrylamide  gels (see  Materials and Methods 
for details). The left panel shows the results obtained using wild-type (wt) and mutant C3 (C3) RSV glycoproteins,  and the right 
panel shows the results of control experiments using wild-type (HA)  and anchor-minus (HAa-) hemagglutinin polypeptides. Notice 
that the C3 polypeptides were present in the soluble, cytosol fractions. 
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The nuclear membrane and the RER have long been known 
to be continuous, and because of the presence of ribosomes 
on the outer nuclear membrane, it has generally been thought 
that glycoproteins could be synthesized randomly either on 
the RER proper or on the nuclear membrane. Consistent with 
these  ideas are the  reports of several mutant glycoproteins 
whose  transport  to  the  Golgi  apparatus  is  blocked;  these 
mutant proteins have been found by immunofluorescence to 
accumulate in the RER as well as on the nuclear membrane 
(for exam#e,  references 3,  51,  58).  Even the VSV anchor- 
minus  glycoprotein,  which  is  secreted  at  a  slow  rate  but 
presumably remains soluble, has been found to accumulate 
around the nucleus of producing cells (11,  50). The wild-type 
forms of these  and  other  (12,  13)  glycoproteins are  found 
predominantly in the Golgi apparatus, and this apparently is 
due to the rapid rates at which they are transported out of the 
RER (with half-times of ~ 10 min). In contrast, the wild-type 
RSV  glycoprotein  is  transported  very  slowly to  the  Golgi 
apparatus. In RSV-infected avian cells, Pr95 env has a half-life 
of~2 h (4) and in CV-1 cells the half-life is similar---2.5 h. 
Consequently, the wild-type RSV glycoproteins are found by 
immunofluorescence to be accumulated in the RER and on 
the  nuclear membrane (as well as in the Golgi apparatus). 
Because of this,  we expected the C3 glycoprotein, which  is 
not transported efficiently to the Golgi apparatus, to produce 
(if  anything)  even  brighter  rings  of  immunofluorescence 
around the  nuclei.  To our surprise, however, we found no 
rings. We propose from these observations that proteins syn- 
thesized in the RER move to the nuclear membrane before 
transport to the Golgi apparatus. Moreover, movement to the 
nuclear  membrane  may require  a  specific transport  event 
even though the RER and nuclear membranes appear to be 
continuous.  These hypotheses are supported by recent evi- 
dence that indicates that transitional vesicles (for the transport 
of glycoproteins to the Golgi apparatus) may be derived from 
"blebs" in the nuclear membrane (2). To our knowledge, this 
is the first report of a mutant glycoprotein that accumulates 
in the RER, but does not accumulate on the nuclear mem- 
brane. 
The failure of a  glycoprotein to be transported is due to 
either its lack of a sorting signal or its lack of solubility in the 
environment of the transport pathway. For example, nongly- 
cosylated VSV glucoprotein (synthesized in the presence of 
tunicamycin) is not transported to the cell surface, but exists 
intracellularly in a  form that is insoluble even in nonionic 
detergents such as Triton X-100 (35).  It appears that the C3 
polypeptides are soluble in the lumen of the RER because 
they were not strictly associated with the pelleted (membrane) 
material during the fractionation experiment, even though no 
detergents were  included  in  our experiments.  Indeed,  they 
behaved exactly like the  pulse-labeled control  polypeptides 
(HAa-), which are presumed to be soluble owing to their rapid 
secretion by the cell. Furthermore, the distribution of labeled 
C3 polypeptides in the membrane and cytosol fractions re- 
mained the same after a 4-h chase as it was before the chase. 
Nevertheless, it could be argued that the C3 polypeptides form 
only small aggregates that are incapable of being transported 
but capable of spilling into the cytosol. Alternatively, it could 
be argued that the C3 polypeptides observed in the cytosol 
were aggregated in very small vesicles that failed to be pelleted 
by the  centrifugation.  We  are  currently investigating these 
two possibilities by determining the sedimentation rate and 
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the protease sensitivity of the C3  protein in the cytosol. A 
shortcoming of these and all other simple methods of evalu- 
ating solubility (see,  for example, references 58,  60) is that 
they require  disruption  of the  cell.  Thus,  regardless of the 
results, it can always be argued that the polypeptides, though 
soluble in the cytosol, are aggregated in vivo. 
Mutants C1 and C2 
Mutants  CI  and  C2  contain  alterations  only within  the 
cytoplasmic domain of the RSV glycoproteins. A number of 
such mutations have been characterized for other membrane- 
bound  glycoproteins.  Some  of these  mutations  apparently 
have no effect on the appearance of the proteins on the cell 
surface (12, 45, 74), but careful kinetic analyses have not been 
performed to determine effects on the rates of  transport. Other 
cytoplasmic domain  mutations  have  been  found  to  have 
striking effects on transport (51,  58). 
The rates at which glycoproteins are transported from the 
RER to the Golgi apparatus are typically measured by deter- 
mining the rates at which resistance to Endo H are acquired 
(for example, 38,  51,  61).  This enzyme removes the simple, 
high  mannose oligosaccharide (added in the RER) but not 
the complex, terminal oligosaccharides (generated in the Golgi 
apparatus) from the polypeptide backbone (25,  65).  The use 
of Endo  H  to  measure  the  rate  of transport  of the  RSV 
glycoprotein is complicated by several features intrinsic to the 
glycoprotein. First of all,  determination  of the  amino acid 
sequence of Pr95 env has shown that a large number (sixteen) 
of potential glycosylation sites are present, and apparently all 
of these are occupied in vivo (29).  Perhaps because of this, 
great heterogeneity of oligosaccharide processing is observed 
(28),  such  that  both cell-associated forms (see  Fig.  3)  and 
virion forms (4) ofgp85 and gp37 appear as very broad smears 
in SDS polyacrylamide gels. Some of this heterogeneity is due 
to the presence of hybrid-type oligosaccharides on the RSV 
glycoproteins  (27).  These  hybrid-type  oligosaccharides  are 
produced in the Golgi apparatus and contain complex oligo- 
saccharide  structures  but  nevertheless  remain  sensitive  to 
Endo H (27, 66). Thus, when gp85 and gp37 are digested with 
Endo H, the proteins migrate faster, in even broader bands in 
SDS polyacrylamide gels than before treatment, even though 
they have been transported to the Golgi apparatus (data not 
shown). A second and perhaps more serious limitation to the 
use of Endo H is the failure ofgp85 and gp37 to accumulate 
in the cell.  Because the glycoproteins are transported to the 
cell surface (and do not appear in the growth medium), we 
hypothesize that degradation occurs after arrival on the cell 
surface. It is interesting that the majority of gp85 and gp37 
produced in RSV-infected avian cells is also degraded (4). 
Because of the limitations prohibiting the use of Endo H, 
we sought an alternative method for measuring transport rates 
to the Golgi apparatus. Labeling experiments using [3H]pal- 
3  mitic acid and [ H]fucose (described in Results) suggested that 
Pr95 e'v is cleaved in the Golgi apparatus to produce gp85 and 
gp37,  so  we  decided  to  use  precursor  disappearance  as  a 
measure of transport. However, because the precise subeellu- 
lar location of palmitate addition has not been resolved for 
mammalian cells (54, 55), our analyses may reflect transport 
from one  RER  compartment to another rather than  from 
RER to the Golgi apparatus. In further support of the latter 
possibility, we have recently constructed (manuscript in prep- 
aration) a mutant RSV glycoprotein with an altered (deleted) 
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paratus (as demonstrated by double fluorescence staining) but 
not to the cell surface (as shown by surface immunofluores- 
cence). This transport-defectiVe mutant protein is not cleaved 
to gp85 and gp37, and the precursor disappears at a very slow 
rate.  We believe that precursor disappearance is not due to 
nonspecific degradation in the RER  for two reasons. First, 
the experiments with mutant C3  polypeptides (which accu- 
mulate in  the  RER)  show that  protein  degradation  in  the 
RER  occurs slowly. Second, pulse-chase experiments using 
short chase  periods  (<2  h)  indicate  that  the rate  at  which 
steady-state levels of gp85 and gp37 are established correlate 
with  the  rate  of precursor  disappearance  during  extended 
chases (data not shown). 
By using precursor disappearance as a measure of transport, 
we examined the effects of mutations in the conserved and 
nonconserved regions of the cytoplasmic domain of Pr95 en~ 
(29). We found that replacement of the nonconserved region 
with another, longer sequence of amino acids (mutant C1) 
had no effect on transport; however, deletion of a portion of 
the conserved region (mutant C2) resulted in slower transport. 
Thus,  it  appears that the cytoplasmic domain  of the  RSV 
glycoproteins is involved in some manner with transport to 
the Golgi apparatus, as is the cytoplasmic domain of the VSV 
G protein (5 l) and perhaps that of the HA protein of vaccinia 
•  virus (58). It will be of great interest todetermine what effects 
the C 1 and C2 mutations have upon the assembly of  infectious 
virions in avian cells in that it seems !ikely that the conserved 
region of the gp37 cytoplasmic domain might also be involved 
in interactions with other viral proteins during the assembly 
process.  Because infectious DNA  copies of the entire  RSV 
genome are available, it will be straightforward to replace the 
wild-type env gene with the mutant env genes for this purpose. 
One of the basic unanswered questions of sorting mecha- 
nisms is in regard to the number of sorting signals contained 
in a given protein. In the case of the RSV glycoproteins, we 
have shown here that the cytoplasmic domain is important 
for transport. We have also identified mutations of the exter- 
nal domain (of gp85) that alter transport to the cell ~  surface 
(manuscript in preparation). Do these two domains contain 
separate and distinct sorting signals or is the conformation of 
a  single sorting signal (perhaps in the external domain) af- 
fected by the conformation of amino acids in both the external 
and cytoplasmic domains? Along these lines of thinking, we 
are  currently  investigating  the  effects  of mutations in  the 
transmembrane domain upon the transport of the RSV gly- 
coproteins. 
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